SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : The Trump Presidency
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: combjelly who wrote (164671)5/19/2020 8:59:14 AM
From: Lane3  Read Replies (1) of 361653
 
...then you can proceed

If the end objective, a prophylactic functioning as a universal vaccine alternative supported by an RCT, isn't feasible for practical or ethical reasons, then there's no point in doing the preliminaries to an RCT.

The most you can do wrt a prophylactic, seems to me, is surveys and epidemiological studies, which would give additional basis for individual patients and doctors choosing to use the drug if they judged it appropriate, which is marginal enhancement of what we have now.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News